-+ 0.00%
-+ 0.00%
-+ 0.00%

Silo Pharma buys Qwikagents.ai platform assets, expands into AI agent market

PUBT·04/22/2026 20:41:17
Listen to the news
Silo Pharma buys Qwikagents.ai platform assets, expands into AI agent market
  • Silo Pharma bought assets of Qwikagents.ai, expanding into AI technology as a second line of business.
  • Company formed a dedicated subsidiary to operate Qwikagents platform and pursue additional AI infrastructure assets.
  • Qwikagents platform supports deployment of autonomous AI agents, featuring smart-routing technology designed to optimize cost and performance across multiple AI models.
  • Management expects acquisition to create new revenue streams as Silo continues advancing SPC-15 PTSD program toward Phase 1, targeting an IND submission to FDA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silo Pharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604221615PRIMZONEFULLFEED9695204) on April 22, 2026, and is solely responsible for the information contained therein.